Wnt receptor complex

The **Wnt receptor complex** refers to the assembly of cell surface proteins that mediate Wnt signal transduction, particularly in the canonical Wnt/β-catenin pathway. In this pathway, extracellular Wnt ligands (such as Wnt3a or Wnt1) bind to a complex on the cell membrane formed by a seven-transmembrane Frizzled (Fzd) receptor and a single-pass transmembrane co-receptor of the low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6)[1][3][5][6]. This ternary complex brings together the Fzd and LRP5/6 components, allowing phosphorylation events and subsequent recruitment of intracellular scaffolding proteins such as Dishevelled (Dvl), leading to stabilization and nuclear translocation of β-catenin and activation of Wnt target genes[1][3][6]. Wnt signaling is pivotal for embryonic development, stem cell function, tissue homeostasis, and regeneration[2][4]. Aberrant activation or inhibition of this pathway (often via mutations in Wnt pathway components or dysregulation of receptor complex activity) is implicated in a wide range of diseases, most notably cancers, degenerative diseases, and fibrotic disorders[2][3][5]. The Wnt receptor complex as a defined drug target is more a functional assembly rather than a single targetable protein, and active drug discovery efforts focus on its component molecules, such as the Frizzled receptor family, LRP5/6, and Wnt ligand antagonists[4][5][6]. **Note:** While "Wnt receptor complex" is a useful biological term, it is not a single protein or gene product and thus is not precise as a canonical drug target. More accurate canonical forms would be "Frizzled-7 receptor" or "Low-density lipoprotein receptor-related protein 6 (LRP6)" depending on context.

Other names

Frizzled-LRP5/6 receptor complexWnt–Frizzled–LRP complexFrizzled–LRP receptor complex

Inhibition of ligand-receptor interaction (Wnt–Frizzled and/or LRP5/6); Blockade of Wnt ligand secretion (Porcupine inhibition); Blockade of Frizzled or LRP5/6 function with antibodies or antagonists; Disruption of intracellular signaling (downregulation of β-catenin signaling).